DPP4 is a key factor that modulates postprandial hyperglycemia by degrading incretin peptides, i.e., glucagon‐like peptide 1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP), which induce secretion of insulin from pancreatic β cells. The gene discussed is DPP4; the disease is Hyperglycemia.